Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.0B | 2.0B | 1.9B | 2.0B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 25M | 30M | 23M | 25M |
Other operating expenses | 240M | 297M | 231M | 255M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 1.3B | 1.3B | 1.7B | 1.3B |
Tax provision | 262M | 253M | 252M | 276M |
Net income | 1.0B | 1.1B | 1.4B | 1.0B |
Basic EPS | 4.3 | 4.7 | 6.4 | 4.4 |
Diluted EPS | 4.3 | 4.7 | 6.4 | 4.4 |
Basic average shares | 144.2M | 144.3M | 144.2M | 144.2M |
Diluted average shares | 144.2M | 144.3M | 144.2M | 144.2M |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | -21M | -30M | -22M | -30M |
Preferred stock dividends | 360M | 348M | 493M | 346M |